Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Carboxynaphthol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 1/20 | 1.00 |
| ▸ | WDR5 | P61964 | 1/20 | 0.68 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.61 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.61 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.61 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.60 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.60 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.60 |
| ▸ | CFTR | P13569 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | THRB | P10828 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.55 |
| ▸ | ATIC | P31939 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carboxynaphthol SCHEMBL3770341 | 1.00 | LDHA (1.00) | LDHAWDR5NR4A1NR4A2NR4A3 | |
| Carboxynaphthol SCHEMBL2099330 | 1.00 | LDHA (1.00) | LDHAWDR5NR4A1NR4A2NR4A3 | |
| Carboxynaphthol SCHEMBL7257660 | 0.98 | LDHA (0.96) | LDHAWDR5NR4A1NR4A2NR4A3 | |
| Carboxynaphthol SCHEMBL28259598 | 0.98 | LDHA (0.96) | LDHAWDR5NR4A1NR4A2NR4A3 | |
| Carboxynaphthol SCHEMBL27673953 | 0.98 | LDHA (0.96) | LDHAWDR5NR4A1NR4A2NR4A3 | |
| Carboxynaphthol SCHEMBL25371193 | 0.98 | LDHA (0.96) | LDHAWDR5NR4A1NR4A2NR4A3 | |
| Carboxynaphthol SCHEMBL25369919 | 0.98 | LDHA (0.96) | LDHAWDR5NR4A1NR4A2NR4A3 | |
| Carboxynaphthol SCHEMBL1458046 | 0.98 | LDHA (0.96) | LDHAWDR5NR4A1NR4A2NR4A3 | |
| Carboxynaphthol SCHEMBL10943009 | 0.98 | LDHA (0.96) | LDHAWDR5NR4A1NR4A2NR4A3 | |
| Carboxynaphthol SCHEMBL5964608 | 0.98 | LDHA (0.96) | LDHAWDR5NR4A1NR4A2NR4A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 24345 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4745137-A1 | GLUTARIMIDE ISOINDOLINONE SKELETON-BASED COMPOUND | Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) | 2026-05-20 | — | — | EP | claimed |
| EP-4745135-A1 | COMPOUND BASED ON THIO-GLUTARIMIDO ISOINDOLINONE SKELETON AND USE THEREOF | Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) | 2026-05-20 | — | — | EP | claimed |
| CN-122070278-A | Bifunctional protein degradation agent containing aryl substituted heteroaryl and application thereof | 标新生物医药科技(上海)有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122036704-A | Free base crystal form or acid salt of biaryl compound, preparation method and medical application thereof | 江苏豪森药业集团有限公司 | 2026-05-15 | — | — | CN | claimed |
| US-12624050-B2 | Three fused ring derivative-containing salt or crystal form and pharmaceutical composition thereof | SHANGHAI HANSOH BIOMEDICAL CO., LTD. (CN) | 2026-05-12 | — | — | US | claimed |
| US-20260125390-A1 | SOLID FORMS OF MACROCYCLIC COMPOUNDS, SALTS AND FORMULATIONS THEREOF, AND METHODS OF PREPARING AND USING THE SAME | KURA ONCOLOGY INC (US) | 2026-05-07 | — | — | US | claimed |
| EP-4720073-A1 | SOLID FORMS OF A MACROCYCLIC FARNESYLTRANSFERASE INHIBITOR AND FORMULATIONS THEREOF, AND METHODS OF PREPARING AND USING THE MACROCYCLIC COMPOUND AND ITS SOLID FORMS | Kura Oncology, Inc. (US) | 2026-04-08 | — | — | EP | claimed |
| EP-4721739-A1 | CSF-1R INHIBITOR PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF | Abbisko Therapeutics Co., Ltd. (CN) | 2026-04-08 | — | — | EP | claimed |
| EP-4722207-A1 | OXOISOINDOLINYL-SUBSTITUTED TETRAHYDROPYRIMIDINEDIONE DERIVATIVE AND USE THEREOF | Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) | 2026-04-08 | — | — | EP | claimed |
| US-4352860-A | Thermosensitive recording material | RICOH COMPANY, LTD. (JP) | 1982-10-05 | — | — | US | claimed |
| EP-0036534-A1 | An orally administrable drug form comprising a beta-lactam antibiotic and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-30 | — | — | EP | claimed |
| EP-0036145-A1 | An orally administered drug form comprising a polar bioactive agent and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-23 | — | — | EP | claimed |
| EP-0035770-A2 | An orally administered drug form comprising a glycosidic antibiotic and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-16 | — | — | EP | claimed |
| US-4279870-A | Liquid-liquid extraction process for the recovery of tungsten from low level sources | GTE LABORATORIES INCORPORATED (US) | 1981-07-21 | — | — | US | claimed |
| EP-0031561-A2 | A rectally administered suppository comprising a drug and an adjuvant | MERCK & CO. INC. (US) | 1981-07-08 | — | — | EP | claimed |
| US-4203619-A | HEATING THE COATING CONTAINING A CHROMOGENIC MATERIAL, COOLING AND SETTING; SOLVENT-FREE | THE MEAD CORPORATION (US) | 1980-05-20 | — | — | US | claimed |
| US-4159208-A | REACTING ALKALI METAL SALT OF AN AROMATIC CARBOXYLIC ACID AND A METAL SALT IN THE PRESENCE OF CLAY AND ALUMINUM COMPOUND | FUJI PHOTO FILM CO., LTD. (JP) | 1979-06-26 | — | — | US | claimed |
| US-4025609-A | CHELATION | KAO SOAP CO., LTD. (JA) | 1977-05-24 | — | — | US | claimed |
| US-3931228-A | Process for preparing phthalide and naphthalide indicator dyes | POLAROID CORPORATION (US) | 1976-01-06 | — | — | US | claimed |